Antiatherosclerosis induced by ligustrazine against LPS through arachidonic acid signaling pathway

Chinese Pharmacological Bulletin

Volumn 28, Issue 4, 2012, Pages 563-567

  Wang, Guo Feng ^a   Zhao, Xia ^a   Li, Ning ^a   Chen, Dong Mei ^b  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Arachidonic acid; Atherosclerosis; Endothelial cells; Ligustrazine; LPS; MAPK pathway

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; ARACHIDONIC ACID; CYCLOOXYGENASE 2; JANUS KINASE 2; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; STAT3 PROTEIN; TETRAMETHYLPYRAZINE;

ARTICLE; ATHEROSCLEROSIS; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG ANTAGONISM; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN CORONARY AORTIC ENDOTHELIAL CELL; IN VITRO STUDY; PROTEIN EXPRESSION;

EID: 84863224095     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1001-1978.2012.01.028     Document Type: Article

References (16)

1. Libby P, Ridker P M, Hansson G K. Progress and challenges in translating the biology of atherosclerosis[J]. Nature, 2011,473(7347):317-25.
2. Koenen R R, von Hundelshausen P, Nesmelova I V, et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice[J]. Nat Med, 2009,15(1):97-103.
3. Furchgott R F, Zawadzki J V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine [J]. Nature, 1980,288(5789):373-6. (Pubitemid 11169009)
4. Puntmann V O, Bigalke B, Nagel E. Characterization of the inflammatory phenotype in atherosclerosis may contribute to the development of new therapeutic and preventative interventions[J]. Trends Cardiovasc Med, 2010,20(5):176-81.
5. Shih R H, Yang C M. Induction of heme oxygenase-1 attenuates lipopolysaccharide-induced cyclooxygenase-2 expression in mouse brain endothelial cells[J]. J Neuroinflamm, 2010,7:86.
6. Hui X, Li H, Zhou Z, Xu A. Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1[J]. J Biol Chem, 2010,285(14):10273-80.
7. Choi J H, Jeon H J, Park J G, et al. Anti-atherogenic effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice[J]. Atherosclerosis, 2010,212(1):146-52.
8. Sampson A P. FLAP inhibitors for the treatment of inflammatory diseases[J]. Curr Opin Investig Drugs, 2009,10(1):1163-72.
9. Li J S, Liu J X, Wang D, et al. Rhubarb aglycone injection antagonism to inflammatory cascade reaction of rats with cerebral ischemia injury[J]. Chin Pharmacol Bull, 2007,23(1):114-8. (Pubitemid 46657673)
10. Cui L, Wang S X, Liu X Y. The effective mechanism of tetramethylpyrazine in anti-atherosclerosis[J]. Med Recap, 2008,14(22):3491-2.
11. Poeckel D, Zemski Berry K A, Murphy R C, et al. Dual 12/15-and 5-lipoxygenase deficiency in macrophages alters arachidonic acid metabolism and attenuates peritonitis and atherosclerosis in ApoE knock-out mice[J]. J Biol Chem, 2009,284(31):21077-89.
12. Cao R Y, St Amand T, Habenicht A J. Genetic and pharmacological inhibition of the 5-lipoxygenase/leukotriene pathway in atherosclerotic lesion development in ApoE deficient mice[J]. Atherosclerosis, 2009,203(2):395-400.
13. Werz O, Szellas D, Steinhilber D, et al. Arachidonic acid promotes phosphorylation of 5-lipoxygenase at Ser-271 by MAPK-activated protein kinase 2 (MK2) [J]. J Biol Chem, 2002,277(17):14793-800. (Pubitemid 34959961)
14. Neria F, Caramelo C, Peinado H, et al. Mechanisms of endothelial cell protection by blockade of the JAK2 pathway[J]. Am J Physiol Cell Physiol, 2007,292(3):C1123-31. (Pubitemid 46440409)